Previous study demonstrated that Fc/FcγR interactions contribute to the resistance to PD-1 blockade, as evidenced by the depletion of activated CD8 tumor-infiltrating lymphocytes (TILs) upon application of anti-PD-1 antibody with high affinity for FcγRs (5). The gene discussed is PDCD1; the disease is neoplasm.